{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:31:03Z","timestamp":1789047063935,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004702","name":"Universit\u00e0 degli Studi di Genova","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004702","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Device-based innovation in metabolic bariatric surgery (MBS) has proliferated under evidentiary standards that differ substantially from those for pharmaceuticals. This review examines the lifecycle of MBS devices, from regulatory approval to long-term outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a structured literature search of PubMed\/MEDLINE, Embase, and Scopus for English-language publications from January 1990 through May 2026, supplemented by regulatory database searches (FDA, EUDAMED) updated to manuscript submission. Five device categories representing distinct regulatory pathways were selected a priori: adjustable gastric bands (LAGB), implantable gastric stimulation (IGS) and vagal blockade (VBLOC), endoluminal liners (EndoBarrier), and gastric clips (BariClip). Intragastric balloons were excluded as temporary, non-implanted devices with different regulatory and safety profiles. This is a narrative review that used systematic search methods for transparency; it does not claim to be a systematic review or meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The LAGB received FDA approval in 2001 based on 3-year data showing 36.2% excess weight loss (EWL), despite an advisory panel voting 6\u2009\u2212\u20094 that 2-year data were inadequate. Ten-year follow-up from the Teen-LABS study (2025) demonstrated that, among adolescents with retained bands, median BMI was 51.1, a 9.2% increase from baseline in this adolescent cohort. Implantable gastric stimulation failed to show benefit in the sham-controlled SHAPE trial (11.8% vs. 11.7% EWL,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.717). Vagal blockade (VBLOC) showed equivocal results in the ReCharge trial (26.1% vs. 16.9% EWL, missing its prespecified margin) yet received FDA approval in 2015 via the Humanitarian Device Exemption (HDE #H150003). The EndoBarrier received CE marking in 2009 and was widely adopted before being withdrawn; a subsequent rigorous sham-controlled trial (ENDO, 2025) confirmed efficacy but revealed a 3.3% hepatic abscess rate. The BariClip, lacking FDA approval and an active MDR CE mark (EUDAMED search performed April 15, 2026, found no active certificate), has been studied only in small single-center series with short-term follow-up (6\u201324 months).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The history of device innovation in MBS reveals a recurring pattern: regulatory approval or market entry based on limited evidence, followed by gradual recognition of limited efficacy and device-specific complications. As noted in a companion systematic review, these failures are not limited to devices but reflect a broader systemic challenge. Structured oversight, including prospective registration, sham-controlled trials where feasible, post-market registries, and long-term follow-up requirements, is essential to protect patients and preserve the credibility of the field.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11695-026-08871-3","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T07:51:11Z","timestamp":1784533871000},"page":"4983-4990","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From Approval to Evidence: Device Regulation, Long-Term Outcomes, and Conflicts of Interest in Metabolic Bariatric Surgery"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6610-4094","authenticated-orcid":false,"given":"Francesco Saverio","family":"Papadia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"issue":"5","key":"8871_CR1","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/s11695-020-05207-7","volume":"31","author":"L Angrisani","year":"2021","unstructured":"Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery survey 2018: similarities and disparities among the 5 IFSO chapters. Obes Surg. 2021;31(5):1937\u201348.","journal-title":"Obes Surg"},{"issue":"4","key":"8871_CR2","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s11695-012-0864-0","volume":"23","author":"H Buchwald","year":"2011","unstructured":"Buchwald H, Oien DM. Metabolic\/bariatric surgery worldwide 2011. Obes Surg. 2011;23(4):427\u201336.","journal-title":"Obes Surg"},{"issue":"14","key":"8871_CR3","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1001\/jama.292.14.1724","volume":"292","author":"H Buchwald","year":"2004","unstructured":"Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724\u201337.","journal-title":"JAMA"},{"issue":"Suppl 1","key":"8871_CR4","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/S1743-9191(13)60003-5","volume":"11","author":"P Angelos","year":"2013","unstructured":"Angelos P. Ethics and surgical innovation: challenges to the professionalism of surgeons. Int J Surg. 2013;11(Suppl 1):S2\u20135.","journal-title":"Int J Surg"},{"issue":"11","key":"8871_CR5","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1001\/archinternmed.2011.30","volume":"171","author":"DM Zuckerman","year":"2011","unstructured":"Zuckerman DM, Brown P, Nissen SE. Medical device recalls and the FDA approval process. Arch Intern Med. 2011;171(11):1006\u201311.","journal-title":"Arch Intern Med"},{"issue":"9","key":"8871_CR6","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1056\/NEJMhle1113918","volume":"366","author":"DB Kramer","year":"2012","unstructured":"Kramer DB, Xu S, Kesselheim AS. Regulation of medical devices in the United States and European Union. N Engl J Med. 2012;366(9):848\u201355.","journal-title":"N Engl J Med"},{"issue":"12","key":"8871_CR7","doi-asserted-by":"publisher","first-page":"znae283","DOI":"10.1093\/bjs\/znae283","volume":"111","author":"RV Cohen","year":"2024","unstructured":"Cohen RV, Busetto L, Levinson R, et al. International consensus position statement on the role of obesity management medications in the context of metabolic bariatric surgery. Br J Surg. 2024;111(12):znae283.","journal-title":"Br J Surg"},{"issue":"9","key":"8871_CR8","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1001\/jamasurg.2017.1093","volume":"152","author":"AM Ibrahim","year":"2017","unstructured":"Ibrahim AM, Thumma JR, Dimick JB. Reoperation and Medicare expenditures after laparoscopic gastric band surgery. JAMA Surg. 2017;152(9):835\u201342.","journal-title":"JAMA Surg"},{"issue":"9695","key":"8871_CR9","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/S0140-6736(09)61116-8","volume":"374","author":"P McCulloch","year":"2009","unstructured":"McCulloch P, Altman DG, Campbell WB, et al. No surgical innovation without evaluation: the IDEAL recommendations. Lancet. 2009;374(9695):1105\u201312.","journal-title":"Lancet"},{"issue":"10","key":"8871_CR10","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1007\/s11695-022-06220-8","volume":"32","author":"A Haddad","year":"2022","unstructured":"Haddad A, Kow L, Herrera MF, et al. Innovative bariatric procedures and ethics in bariatric surgery: the IFSO position statement. Obes Surg. 2022;32(10):3217\u201330.","journal-title":"Obes Surg"},{"issue":"8","key":"8871_CR11","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1001\/jamasurg.2019.0903","volume":"154","author":"JB Dimick","year":"2019","unstructured":"Dimick JB, Sedrakyan A, McCulloch P. The IDEAL framework for evaluating surgical innovation: how it can be used to improve the quality of evidence. JAMA Surg. 2019;154(8):685\u20136.","journal-title":"JAMA Surg"},{"key":"8871_CR12","volume-title":"Food and Drug Administration. Summary of Safety and Effectiveness Data: LAP-BAND Adjustable Gastric Banding System. PMA P000008","author":"June","year":"2001","unstructured":"June. Food and Drug Administration. Summary of Safety and Effectiveness Data: LAP-BAND Adjustable Gastric Banding System. PMA P000008. Volume 5. Silver Spring, MD: FDA; 2001."},{"issue":"6","key":"8871_CR13","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1097\/00000658-200106000-00011","volume":"233","author":"EJ DeMaria","year":"2001","unstructured":"DeMaria EJ, Sugerman HJ, Meador JG, et al. High failure rate after laparoscopic adjustable silicone gastric banding for treatment of morbid obesity. Ann Surg. 2001;233(6):809\u201318.","journal-title":"Ann Surg"},{"issue":"1","key":"8871_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.soard.2024.10.015","volume":"21","author":"MA Fleming 2nd","year":"2025","unstructured":"Fleming MA 2nd, Jenkins TM, Inge TH, et al. Weight loss and health status 10 years after laparoscopic adjustable gastric band insertion in adolescents: a follow-up report from Teen-LABS. Surg Obes Relat Dis. 2025;21(1):33\u201340.","journal-title":"Surg Obes Relat Dis"},{"issue":"9","key":"8871_CR15","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jama.2014.7651","volume":"312","author":"BN Reames","year":"2014","unstructured":"Reames BN, Finks JF, Bacal D, Carlin AM, Dimick JB. Changes in bariatric surgery procedure use in Michigan, 2006\u20132013. JAMA. 2014;312(9):959\u201361.","journal-title":"JAMA"},{"issue":"4","key":"8871_CR16","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s11695-024-07118-3","volume":"34","author":"L Angrisani","year":"2024","unstructured":"Angrisani L, Santonicola A, Iovino P, et al. IFSO worldwide survey 2020\u20132021: current trends for bariatric and metabolic procedures. Obes Surg. 2024;34(4):1075\u201385.","journal-title":"Obes Surg"},{"issue":"Suppl 1","key":"8871_CR17","doi-asserted-by":"publisher","first-page":"12S","DOI":"10.1007\/BF03342141","volume":"12","author":"V Cigaina","year":"2002","unstructured":"Cigaina V. Gastric pacing as therapy for morbid obesity: preliminary results. Obes Surg. 2002;12(Suppl 1):12S-16S.","journal-title":"Obes Surg"},{"issue":"Suppl 1","key":"8871_CR18","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1007\/BF03342136","volume":"14","author":"M De Luca","year":"2004","unstructured":"De Luca M, Segato G, Busetto L, et al. Progress in implantable gastric stimulation: summary of results of the European multi-center study. Obes Surg. 2004;14(Suppl 1):S33-9.","journal-title":"Obes Surg"},{"issue":"1","key":"8871_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.soard.2008.09.012","volume":"5","author":"SA Shikora","year":"2009","unstructured":"Shikora SA, Bergenstal R, Bessler M, et al. Implantable gastric stimulation for the treatment of clinically severe obesity: results of the SHAPE trial. Surg Obes Relat Dis. 2009;5(1):31\u20137.","journal-title":"Surg Obes Relat Dis"},{"issue":"11","key":"8871_CR20","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1007\/s11695-012-0751-8","volume":"22","author":"MG Sarr","year":"2012","unstructured":"Sarr MG, Billington CJ, Brancatisano R, et al. The EMPOWER study: randomized, prospective, double-blind, multicenter trial of vagal blockade to induce weight loss in morbid obesity. Obes Surg. 2012;22(11):1771\u201382.","journal-title":"Obes Surg"},{"issue":"9","key":"8871_CR21","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1001\/jama.2014.10540","volume":"312","author":"S Ikramuddin","year":"2014","unstructured":"Ikramuddin S, Blackstone RP, Brancatisano A, et al. Effect of reversible intermittent intra-abdominal vagal nerve blockade on morbid obesity: the ReCharge randomized clinical trial. JAMA. 2014;312(9):915\u201322.","journal-title":"JAMA"},{"key":"8871_CR22","doi-asserted-by":"publisher","first-page":"365604","DOI":"10.1155\/2015\/365604","volume":"2015","author":"SA Shikora","year":"2015","unstructured":"Shikora SA, Wolfe BM, Apovian CM, et al. Sustained weight loss with vagal nerve blockade but not with sham: 18-month results of the ReCharge trial. J Obes. 2015;2015:365604.","journal-title":"J Obes"},{"issue":"1","key":"8871_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.soard.2007.07.012","volume":"4","author":"L Rodriguez-Grunert","year":"2008","unstructured":"Rodriguez-Grunert L, Galvao Neto MP, Alamo M, et al. First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve. Surg Obes Relat Dis. 2008;4(1):55\u20139.","journal-title":"Surg Obes Relat Dis"},{"issue":"6","key":"8871_CR24","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.gie.2009.11.051","volume":"71","author":"KS Gersin","year":"2010","unstructured":"Gersin KS, Rothstein RI, Rosenthal RJ, et al. Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates. Gastrointest Endosc. 2010;71(6):976\u201382.","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"8871_CR25","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/SLA.0b013e3181bdfbff","volume":"251","author":"R Schouten","year":"2010","unstructured":"Schouten R, Rijs CS, Bouvy ND, et al. A multicenter, randomized efficacy study of the EndoBarrier gastrointestinal liner for presurgical weight loss prior to bariatric surgery. Ann Surg. 2010;251(2):236\u201343.","journal-title":"Ann Surg"},{"key":"8871_CR26","doi-asserted-by":"crossref","unstructured":"Thompson CC, Jirapinyo P, McCarty TR et al. A multicenter double-blind randomized sham-controlled trial assessing the EndoBarrier duodenal-jejunal bypass liner for the treatment of poorly controlled type 2 diabetes mellitus with concomitant obesity: the ENDO Trial. Ann Surg. 2025 Nov 7. Epub ahead of print.","DOI":"10.1097\/SLA.0000000000006974"},{"issue":"7","key":"8871_CR27","doi-asserted-by":"publisher","first-page":"e14827","DOI":"10.1111\/dme.14827","volume":"39","author":"REJ Ryder","year":"2022","unstructured":"Ryder REJ, Yadagiri M, Burbridge W, Irwin SP, et al. Duodenal-jejunal bypass liner for the treatment of type 2 diabetes and obesity: 3-year outcomes in the First National Health Service (NHS) EndoBarrier Service. Diabet Med. 2022;39(7):e14827.","journal-title":"Diabet Med"},{"issue":"5","key":"8871_CR28","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1007\/s11695-016-2432-5","volume":"27","author":"M Jacobs","year":"2017","unstructured":"Jacobs M, Zundel N, Plasencia G, et al. A vertically placed clip for weight loss: a 39-month pilot study. Obes Surg. 2017;27(5):1174\u201381.","journal-title":"Obes Surg"},{"issue":"10","key":"8871_CR29","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/j.soard.2018.07.013","volume":"14","author":"P Noel","year":"2018","unstructured":"Noel P, Nedelcu AM, Eddabali I, Zundel N. Laparoscopic vertical clip gastroplasty \u2014 quality of life. Surg Obes Relat Dis. 2018;14(10):1587\u201393.","journal-title":"Surg Obes Relat Dis"},{"issue":"10","key":"8871_CR30","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1007\/s11695-023-06780-3","volume":"33","author":"P Noel","year":"2023","unstructured":"Noel P, Olmi S, Gentileschi P, et al. Classification of slippage following laparoscopic BariClip gastroplasty. Obes Surg. 2023;33(10):3317\u201322.","journal-title":"Obes Surg"},{"issue":"1","key":"8871_CR31","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s11695-024-07603-9","volume":"35","author":"E Benitez Navarrete","year":"2025","unstructured":"Benitez Navarrete E, Garcia Garza M, Islas Trevi\u00f1o D, et al. Laparoscopic vertical clip gastroplasty with BariClip: experience, complications, literature review, and proposal of modification of the original technique. Obes Surg. 2025;35(1):322\u20138.","journal-title":"Obes Surg"},{"issue":"11","key":"8871_CR32","doi-asserted-by":"publisher","first-page":"e0337334","DOI":"10.1371\/journal.pone.0337334","volume":"20","author":"S Abualhaj","year":"2025","unstructured":"Abualhaj S, Alyazouri A, Abualhaj MM, et al. Retrospective analysis of the BariClip procedure: clinical outcomes and complication profile. PLoS ONE. 2025;20(11):e0337334.","journal-title":"PLoS ONE"},{"issue":"11","key":"8871_CR33","doi-asserted-by":"publisher","first-page":"4220","DOI":"10.1007\/s11695-024-07522-9","volume":"34","author":"M Bonaldi","year":"2024","unstructured":"Bonaldi M, Uccelli M, Lee YH, et al. BariClip: outcomes and complications from a single-center experience. Obes Surg. 2024;34(11):4220\u20137.","journal-title":"Obes Surg"},{"issue":"8","key":"8871_CR34","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1007\/s11695-021-05466-y","volume":"31","author":"PC Chang","year":"2021","unstructured":"Chang PC, Chen KH, Huang IYW, et al. Laparoscopic revision for gastric clipping: a single center experience and Taiwan database review. Obes Surg. 2021;31(8):3653\u201360.","journal-title":"Obes Surg"},{"issue":"2","key":"8871_CR35","first-page":"246","volume":"148","author":"JP Angelchik","year":"1979","unstructured":"Angelchik JP, Cohen R. A new surgical procedure for the treatment of gastroesophageal reflux and hiatal hernia. Surg Gynecol Obstet. 1979;148(2):246\u20138.","journal-title":"Surg Gynecol Obstet"},{"issue":"5","key":"8871_CR36","first-page":"423","volume":"34","author":"A Aiolfi","year":"2024","unstructured":"Aiolfi A, Bona D, Sozzi A, Bonavina L. Scoping review of device-related foregut erosions: the Angelchik prosthesis and beyond. J Laparoendosc Adv Surg Tech A. 2024;34(5):423\u201332.","journal-title":"J Laparoendosc Adv Surg Tech A"},{"issue":"4","key":"8871_CR37","doi-asserted-by":"publisher","first-page":"295","DOI":"10.7326\/0003-4819-148-4-200802190-00008","volume":"148","author":"I Boutron","year":"2008","unstructured":"Boutron I, Moher D, Altman DG, et al. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med. 2008;148(4):295\u2013309.","journal-title":"Ann Intern Med"},{"issue":"5","key":"8871_CR38","doi-asserted-by":"publisher","DOI":"10.1093\/bjs\/znag047","volume":"113","author":"FS Papadia","year":"2026","unstructured":"Papadia FS, De Cian O, Di Lorenzo N, Cohen RV. Navigating uncharted territory in surgical innovation: systematic review of non-standard metabolic bariatric surgery procedures. Br J Surg. 2026;113(5):znag047.","journal-title":"Br J Surg"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-026-08871-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-026-08871-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-026-08871-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:54:58Z","timestamp":1789044898000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11695-026-08871-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["8871"],"URL":"https:\/\/doi.org\/10.1007\/s11695-026-08871-3","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"18 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}